LumiThera is committed to creating a brighter horizon for patients by developing treatment solutions utilizing Photobiomodulation to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness. LumiThera’s first product, the Valeda Light Delivery System, is the first approved treatment for Dry Age-Related Macular Degeneration using Photobiomodulation. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease of use in the clinician’s office. The Valeda Light Delivery System is in clinical trials and not approved for use in the United States. Visit www.lumithera.com to learn more.